A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Xiaonan,Zhang ^[1] ; Simin,Min ^[2] ; Yifan,Yang ^[1] ; Dushan,Ding ^[2] ; Qicai,Li ^[3] ; Saisai,Liu ^[1] ; Tao,Tao ^[2] ; Ming,Zhang ^[3] ; Baiqing,Li ^[1] ; Shidi,Zhao ^[2] ; Rongjing,Ge ^[3] ; Fan,Yang ^[2] ; Yan,Li ^[4] ; Xiaoyu,He ^[1] ; Xiaoxiao,Ma ^[2] ; Lian,Wang ^[1] ; Tianyu,Wu ^[2] ; Tao,Wang ^[2] ; Guowen,Wang ^[2]

作者单位： Department of Pathophysiology, Bengbu Medical College, Bengbu, China. ^[1] Bengbu Medical College Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu, China. ^[2] Department of Thoracic Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China. ^[3] Department of Immunology, Bengbu Medical College, Bengbu, China. ^[4] Department of Preventive Medicine, Bengbu Medical College, Bengbu, China. ^[5] College of Life and Health Sciences, Northeastern University, Shenyang, China. ^[6]

关键词 LUAD TIM TP53 immune prognostic model immunotherapy

主题词人类(Humans);肺肿瘤(Lung Neoplasms);突变(Mutation);预后(Prognosis);存活率(Survival Rate);肿瘤微环境(Tumor Microenvironment);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)

DOI 10.3389/fimmu.2022.876355

PMID 35837383

发布时间 2022-07-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in immunology

2022年13卷

876355页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

检索历史清除